Copyright
©2010 Baishideng. All rights reserved.
World J Gastroenterol. Mar 14, 2010; 16(10): 1226-1231
Published online Mar 14, 2010. doi: 10.3748/wjg.v16.i10.1226
Published online Mar 14, 2010. doi: 10.3748/wjg.v16.i10.1226
Microalbuminuria in hepatitis C-genotype 4: Effect of pegylated interferon and ribavirin
Moutaz Derbala, Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, 00974, State of Qatar; Department of Medicine, Weill Cornell Medical College in Qatar, Doha, 00974, State of Qatar
Fatma M Shebl, Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, United States; Epidemiology Branch, National Liver Institute, Shibin Elkom, Menoufia, 32511, Egypt
Awad Rashid, Department of Nephrology, Hamad Medical Corporation, Doha, 00974, State of Qatar
Aliaa Amer, Department of Laboratory Medicine and Histopathology, Hematology Section, Hamad Medical Corporation, Doha, 00974, State of Qatar
Abdulbari Bener, Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, Doha, 00974, State of Qatar
Author contributions: All authors have actively participated in data collection and patients’ follow-up; Shebl FM and Bener A performed the statistical analysis; the principal investigator Derbala M wrote the manuscript; all co-authors reviewed the manuscript.
Correspondence to: Moutaz Derbala, MD, PhD, Department of Gastroenterology and Hepatology, Hamad Medical Corporation, PO Box 3050, Doha, 00974, State of Qatar. moutazderbala@hotmail.com
Telephone: +974-5355671 Fax: +974-4392279
Received: October 2, 2009
Revised: November 3, 2009
Accepted: November 10, 2009
Published online: March 14, 2010
Revised: November 3, 2009
Accepted: November 10, 2009
Published online: March 14, 2010
Core Tip